Dr. Sidharth Prasad Mishra, DVM, PhD, is a postdoctoral scientist whose research centers on host–microbiome interactions, metabolic endotoxemia, and systemic inflammation in the pathogenesis of chronic diseases. His work dissects how gut microbial dysbiosis, leaky gut, and inflammatory signaling contribute to obesity and type 2 diabetes (T2D) and how these metabolic disturbances escalate the risk of colorectal cancer (CRC) and Alzheimer’s disease (AD). Through multi-omics, immunometabolic, and molecular approaches, Dr. Mishra investigates how microbial metabolites, lipopolysaccharide (LPS) translocation, and microRNA networks regulate epithelial barrier integrity, insulin resistance, and neuroinflammation. His studies have revealed key mechanisms linking metabolic inflammation with tumorigenesis and cognitive decline, identifying shared inflammatory and epigenetic nodes that drive both CRC initiation and neurodegenerative progression. He integrates gut and brain biology to define how systemic inflammation bridges the metabolic–intestinal–neuronal axis, shaping vulnerability to AD in obese and diabetic states. Dr. Mishra’s translational goal is to develop microbiota-targeted interventions, including probiotics, postbiotics, and microbial-mimetic metabolites, to restore gut homeostasis, prevent endotoxemia, and interrupt inflammatory crosstalk among the gut, liver, and brain. His research vision connects basic mechanistic discovery with therapeutic innovation.